Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Pharmaxis Ltd ( (AU:SNT) ) just unveiled an update.
Syntara Limited has announced a new application for the quotation of 1,500,000 fully paid ordinary securities on the Australian Securities Exchange (ASX) under the code SNT, with the issue date set for July 31, 2025. This move is part of the company’s strategy to enhance its market presence and liquidity, potentially impacting its operational capabilities and offering new opportunities for stakeholders.
The most recent analyst rating on (AU:SNT) stock is a Buy with a A$0.12 price target. To see the full list of analyst forecasts on Pharmaxis Ltd stock, see the AU:SNT Stock Forecast page.
More about Pharmaxis Ltd
Average Trading Volume: 9,903,436
Technical Sentiment Signal: Sell
Current Market Cap: A$92.68M
Learn more about SNT stock on TipRanks’ Stock Analysis page.